About the Authors

Effy Vayena

effy.vayena@hest.ethz.ch

Affiliation Health Ethics and Policy Lab, Department of Health Sciences and Technology, ETH Zurich, Zurich, Switzerland

Alessandro Blasimme

Affiliation Health Ethics and Policy Lab, Department of Health Sciences and Technology, ETH Zurich, Zurich, Switzerland

I. Glenn Cohen

Affiliation Harvard Law School, Cambridge, Massachusetts, United States of America

Competing Interests

I have read the journal’s policy and the authors of this manuscript have the following competing interests: EV has received speaking fees from SwissRe, Novartis R&D Academy, and Google Netherlands. IGC served as a consultant for Otsuka Pharmaceuticals advising on the use of digital medicine for its Abilify MyCite product. IGC is supported by the Collaborative Research Program for Biomedical Innovation Law, which is a scientifically independent collaborative research program supported by Novo Nordisk Foundation. AB served as a consultant for Celgene Corporation for the preparation of a workshop on pharmaceutical innovation and received honoraria from SwissRe for participating at an internal event on genome editing.